U.S. Communications Stock News

NasdaqGM:CRSP
NasdaqGM:CRSPBiotechs

Casgevy Uptake Grows As CRISPR Therapeutics Shares Trade Below Estimates

CRISPR Therapeutics reported a threefold increase in Casgevy patient initiations for sickle cell disease and beta thalassemia over the past year. The company highlighted ongoing commercial rollout progress alongside continued net losses. Management pointed to a strong cash position as support for both Casgevy expansion and further R&D. CRISPR Therapeutics, trading on NasdaqGM:CRSP, is in the spotlight as Casgevy gains early traction in the gene therapy market. The stock closed at $57.33,...
NasdaqGS:RXRX
NasdaqGS:RXRXBiotechs

Recursion Pharmaceuticals (RXRX) Is Down 6.1% After Insider Sale And New ATM Equity Program - Has The Bull Case Changed?

In late February 2026, Recursion Pharmaceuticals reported fourth-quarter 2025 revenue of US$35.54 million with a quarterly net loss of US$108.12 million, and around the same time filed a US$300 million at-the-market follow-on equity offering plus a US$68.57 million shelf registration tied to an ESOP. Shortly after these filings, Director Blake Borgeson sold 170,000 Class A shares while still retaining more than 6.25 million shares, drawing attention to insider sentiment alongside the...
NYSE:NRG
NYSE:NRGElectric Utilities

A Look At NRG Energy’s Valuation After A Strong Year And Recent Pullback

Event overview and why NRG Energy is on investors’ radar NRG Energy (NRG) has attracted fresh attention after a strong 1 year total return of 78.24%, standing out against more muted recent moves over the past week and month. That contrast between short term pullback and longer term strength is prompting investors to reassess how the company’s US$30,713.0m in revenue and US$797.0m in net income line up with current pricing. See our latest analysis for NRG Energy. At a share price of US$160.46,...
NYSE:GOLF
NYSE:GOLFLeisure

Assessing Acushnet Holdings (GOLF) Valuation After Recent Short Term Share Price Weakness

Assessing Acushnet Holdings after recent share price moves Acushnet Holdings (GOLF) has recently seen mixed share price performance, with a 2.3% decline over the past day and a 5.6% decline over the past week, alongside gains over the past 3 months and year. See our latest analysis for Acushnet Holdings. Putting that into context, the recent 1-day and 7-day share price declines sit against a stronger 90-day share price return of 16.4% and a 1-year total shareholder return of 44.0%. This...
NYSE:JBS
NYSE:JBSFood

Assessing JBS (NYSE:JBS) Valuation After Recent Short Term Share Price Weakness

JBS stock snapshot and recent performance JBS (NYSE:JBS) has recently drawn investor attention as its shares trade around $15.65, with returns showing mixed short term moves and a positive shift over the past 3 months and year to date. See our latest analysis for JBS. Despite a recent 1-day share price return decline of 4.16% and a 7-day share price return decline of 5.89%, JBS still shows a 90-day share price return of 9.06% and a year to date share price return of 10.37%. This suggests...
NYSE:LMT
NYSE:LMTAerospace & Defense

Lockheed Martin Advances Secure Tech Partnerships While Shares Trade Near Fair Value

Lockheed Martin (NYSE:LMT) is partnering with Mitsubishi Electric to supply anti jamming payloads for Japan's next generation defense satellites. The company is working with Teradar to test terahertz sensing technology for battlefield perception in challenging environments. Lockheed Martin is collaborating with Xanadu on quantum machine learning focused on defense and national security applications. For you as an investor looking at NYSE:LMT, these agreements sit in the core of the...
NYSE:ATMU
NYSE:ATMUMachinery

A Look At Atmus Filtration Technologies (ATMU) Valuation As Oil Price Shock Raises Inflation Concerns

Oil price shock and inflation fears hit Atmus Filtration Technologies (ATMU) Atmus Filtration Technologies (ATMU) came under pressure after crude oil prices jumped on escalating conflict with Iran, raising concerns about renewed inflation and the prospect of more challenging central bank interest rate decisions. See our latest analysis for Atmus Filtration Technologies. Despite the latest 2.97% 1 day share price decline to $61.84, Atmus Filtration Technologies still has a 1 month share price...
NasdaqGS:HBAN
NasdaqGS:HBANBanks

Assessing Huntington Bancshares (HBAN) Valuation After Recent Share Price Weakness And Conflicting Fair Value Signals

Huntington Bancshares at a glance Huntington Bancshares (HBAN) has drawn attention after recent share price weakness, with the stock down about 9% over the past month and modestly lower over the past 3 months. At a last close of $16.68, the regional bank carries a value score of 3 and reports annual revenue of $7,692.0 and net income of $2,087.0, both stated with positive annual growth rates. See our latest analysis for Huntington Bancshares. The recent 9.3% 30 day share price decline and...
NasdaqGS:ZM
NasdaqGS:ZMSoftware

A Look At Zoom Communications (ZM) Valuation After Sector Rally And Consecutive Earnings Beats

Zoom Communications (ZM) is back in focus after a sector wide rally spotlighted enterprise software names, just days after the company reported quarterly results that exceeded its guidance midpoint for a third straight time. See our latest analysis for Zoom Communications. Even after the sector rally and the latest earnings beat, Zoom’s share price of US$77.33 sits below its recent highs, with a 30 day share price return of 12.85% decline and a year to date share price return of 7.19%...
NYSE:TRV
NYSE:TRVInsurance

Travelers Insider Sales Contrast With Strong AI Driven Underwriting Performance

Executives at Travelers Companies (NYSE:TRV) have recently carried out significant insider share sales, drawing attention to management's trading activity. The company has reported strong operating performance supported by underwriting gains, higher investment income, and efficiencies linked to AI tools. Travelers Companies sits at a current share price of $306.64. The stock is up 21.7% over the past year, 85.7% over the past 3 years, and 117.4% over the past 5 years. For investors looking...
NYSE:LVS
NYSE:LVSHospitality

A Look At Las Vegas Sands (LVS) Valuation After Major Leadership Changes And Expansion Plans

Las Vegas Sands (LVS) has put fresh leadership at the center of its story, with Patrick Dumont now serving as chairman, chief executive officer, president, and treasurer, alongside new five year agreements for other senior executives. See our latest analysis for Las Vegas Sands. The leadership reshuffle lands at a time when the share price has eased back, with a 90 day share price return of 16.77% decline and a year to date share price return of 15.44% decline. At the same time, the 1 year...
NasdaqGM:OABI
NasdaqGM:OABILife Sciences

OmniAb (OABI) Q4 Revenue Surge To US$8.4 Million Tests Bearish Loss Concerns

OmniAb (OABI) has posted its FY 2025 numbers with Q4 revenue of US$8.4 million and a basic EPS loss of US$0.11, alongside a trailing twelve month revenue figure of US$18.7 million and a basic EPS loss of US$0.57. Over recent quarters, the company has reported quarterly revenue in a range between US$2.2 million and US$10.8 million, while basic EPS losses have ranged from US$0.11 to US$0.17, leaving margins in loss-making territory and keeping the focus on how efficiently that revenue is being...
NasdaqGS:POWI
NasdaqGS:POWISemiconductor

Is It Time To Reassess Power Integrations (POWI) After Its Recent Share Price Rebound?

If you are wondering whether Power Integrations is attractively priced right now, it helps to separate the share price story from what the underlying valuation is actually saying. The stock closed at US$47.81 most recently, after a 5.7% gain over the last 30 days, with a 28.2% return year to date, alongside an 18.3% decline over the past year and a 40.0% decline over five years. Recent attention on Power Integrations has centered on its position in the semiconductor space and how investors...
NasdaqGS:LRCX
NasdaqGS:LRCXSemiconductor

A Look At Lam Research (LRCX) Valuation After Geopolitical And AI Export Concerns Weigh On Shares

Lam Research (LRCX) shares dropped after renewed concerns about Middle East tensions, with investors reacting to potential energy price shocks, higher liquefied natural gas costs in South Korea, and possible new AI chip export rules. See our latest analysis for Lam Research. The recent 3.7% one day share price drop to US$214.68 and 10.2% 7 day share price decline come after months of strong momentum, with a 35.3% 90 day share price return and very large multi year total shareholder returns...
NasdaqGS:STOK
NasdaqGS:STOKBiotechs

Is NEJM Zorevunersen Data And Phase 3 EMPEROR Plans Altering The Investment Case For Stoke Therapeutics (STOK)?

In late February 2026, Stoke Therapeutics and Biogen reported in The New England Journal of Medicine that their investigational Dravet syndrome therapy zorevunersen produced substantial, durable reductions in seizures and multi‑year cognitive and behavioral benefits, while Stoke also outlined a Phase 3 EMPEROR timeline and plans for a rolling FDA submission. These clinical and regulatory updates suggest zorevunersen could shift treatment expectations in Dravet syndrome and intensify focus on...
NYSE:DRI
NYSE:DRIHospitality

Will Margin-Focused Pricing and Promotions Change Darden Restaurants' (DRI) Resilient Income Narrative?

Darden Restaurants recently updated investors on its past quarter, outlining softer guest traffic, selective price increases, and tight cost control across Olive Garden, LongHorn Steakhouse, and other brands to protect industry-leading margins. Management’s emphasis on disciplined promotions and maintaining strong restaurant-level profitability, while still funding dividends, highlights Darden’s role as a relatively resilient, income-oriented casual dining operator. We’ll now examine how...
NasdaqGS:INTU
NasdaqGS:INTUSoftware

Intuit (INTU) Is Up 18.3% After Strong Q2, Higher Dividend And Anthropic AI Deal - Has The Bull Case Changed?

In late February 2026, Intuit Inc. reported higher revenue and earnings for its fiscal second quarter and first half, reaffirmed full‑year guidance, and approved a US$1.20 quarterly dividend per share, a 15% increase from the prior year period. At the same time, Intuit’s new multi‑year AI partnership with Anthropic aims to embed custom financial AI agents across mid‑market businesses and consumer experiences, potentially deepening usage of its TurboTax, QuickBooks, Credit Karma, and...
NasdaqCM:ALMU
NasdaqCM:ALMUSemiconductor

A Look At Aeluma (ALMU) Valuation After Positive Analyst Commentary Linked To Nvidia Optical Investments

Why Aeluma (ALMU) Is Back on Investors’ Radar Recent analyst commentary on Aeluma (ALMU), linking the company to favorable read-through from Nvidia’s optical investments, has sparked fresh interest following the stock’s short-term move of about 4.88%. See our latest analysis for Aeluma. That 4.88% short-term move around the recent analyst commentary sits against a share price of US$15.72 and a softer near term pattern, with the 1-day, 7-day and 90-day share price returns all in decline, even...
NasdaqGS:GOOGL
NasdaqGS:GOOGLInteractive Media and Services

Alphabet (GOOGL) Valuation Check After Recent Share Price Pullback

Alphabet stock performance snapshot Alphabet (GOOGL) has seen mixed share price moves recently, with a 1 day return of around a 1% decline and a 7 day return of roughly a 2% decline. This sets the context for a deeper look at its fundamentals. See our latest analysis for Alphabet. While Alphabet’s 1 month share price return of around 11% decline and year to date share price return of about 5% decline point to cooling momentum in the short term, the 1 year total shareholder return of roughly...
NasdaqGS:ZVRA
NasdaqGS:ZVRAPharmaceuticals

A Look At Zevra Therapeutics (ZVRA) Valuation After Recent Share Price Moves

Why Zevra Therapeutics (ZVRA) Is On Investors’ Radar Zevra Therapeutics (ZVRA) has been drawing attention after recent share price moves, with the stock down about 4% over the past month but up roughly 1% in the past 3 months. See our latest analysis for Zevra Therapeutics. At a latest share price of US$8.79, Zevra Therapeutics has seen short term share price pressure with a 7 day return of 3.3% and 30 day return of 4.0%. Its 1 year total shareholder return of 9.2% and 3 year total...
NYSE:VRT
NYSE:VRTElectrical

Does Vertiv’s New AI‑Driven Financing and BYOP&C Strategy Redefine the Bull Case For VRT?

In recent days, Vertiv Holdings Co completed an inaugural US$2.10 billion investment‑grade senior unsecured notes offering, refinanced its revolving credit facility, and expanded its AI-focused PowerBar Track busway range while rolling out a high-fidelity Digital Twin platform and a Bring Your Own Power & Cooling collaboration with Generate Capital for grid-constrained U.S. data centers. Together, these financing moves, AI-centric product launches, and infrastructure partnerships point to...
NasdaqGS:PCAR
NasdaqGS:PCARMachinery

Assessing PACCAR (PCAR) Valuation After Record 2025 Results And Moderate Buy Consensus

Why PACCAR’s latest results matter for investors PACCAR (PCAR) has released robust 2025 financial results, with record outcomes in its Parts and Financial Services segments, a material update that is likely front of mind for investors watching the stock’s recent performance. The company reported revenue of US$28.44b and net income of US$2.38b, while the share price has risen about 12% over the past 3 months yet still lagged its wider industrial sector peers. See our latest analysis for...
NasdaqGS:AMZN
NasdaqGS:AMZNMultiline Retail

Amazon Weighs AWS Security Risks Against Expanding Global AI Data Centers

Drone strikes hit multiple Amazon Web Services data centers in the United Arab Emirates and Bahrain, causing damage and extended outages. Amazon.com, NasdaqGS:AMZN, is moving ahead with multibillion-dollar data center investments in Spain focused on AI and cloud capacity. The company has also entered a long-term AI collaboration with OpenAI that ties into its broader data center expansion plans. For investors watching Amazon.com, NasdaqGS:AMZN, the mix of physical risk and digital growth is...
NYSE:CLVT
NYSE:CLVTProfessional Services

Clarivate (CLVT) Valuation Check After Upgraded Earnings Estimates And Recurring Revenue And Debt Updates

Clarivate (CLVT) has been back on investors’ radar after a series of upward earnings estimate revisions, along with recent updates on recurring revenue, debt reduction efforts, and potential asset sales that together reframed the stock’s risk profile. See our latest analysis for Clarivate. The recent 22.75% 1 month share price return, together with a 7.92% gain over 7 days, suggests some near term momentum is returning after a 90 day share price decline of 28.45% and a 1 year total...